Avita Medical Ltd (RCEL) Stock Analysis

Avita Medical Ltd (RCEL) is a publicly traded company in the HEALTHCARE sector. It trades at $4.19, carries a market capitalization of $134.80M. This page summarizes the public market data, fundamentals, and frequently asked questions for RCEL, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

Market Sentiment

Avita Medical Ltd currently has a Bullish sentiment score of 0.15.

About Avita Medical Ltd

AVITA Medical Inc. is a pioneering regenerative medicine company focused on developing innovative treatments for patients with skin-related conditions. Based in Valencia, California, the company operates in the United States, Australia, and the United Kingdom, leveraging its advanced technology in skin cell regeneration to enhance healing processes. With a strong emphasis on clinical efficacy and safety, AVITA aims to transform patient care in wound management and cosmetic solutions, position...

GNG Research Analysis

GNG Research scores Avita Medical Ltd (RCEL) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for RCEL.

Frequently Asked Questions

Does RCEL pay dividends?

Avita Medical Ltd (RCEL) does not currently pay a regular dividend.

What is RCEL's market cap?

Avita Medical Ltd (RCEL) has a market capitalization of $134.80M with a current stock price of $4.19.